Established in 2000, Taro UK has the benefit of Taro’s global resources. With 52 years of experience in developing, manufacturing, and marketing medications used in countries around the world, Taro looks forward to providing the UK with an expanding line of affordable, high-quality branded and generic pharmaceuticals.
This website contains valuable information about Taro UK products for dispensing doctors, pharmacists and consumers. Please visit often to learn more about the ways in which Taro can serve you.
June 14, 2010
Taro Provides Preliminary First Quarter 2010 Financial Results
More 
June 03, 2010
Taro Receives FDA Approval for Granisetron Hydrochloride Tablets
More
April 30, 2010
Taro Provides Preliminary 2009 Full Year Results
More
April 06, 2010
Taro Receives Patent for T2007, the Company's Second Proprietary Non-Sedating Barbiturate Drug
More
March 25, 2010
Taro Files Audited Financials for the Year Ended December 31, 2006 and Restated Financials for 2005 and 2004
More
March 8, 2010
Taro Receives FDA Approval for Fluorouracil Topical Cream USP, 5%
More
February 18, 2010
Taro Announces Planned Discontinuation of Manufacturing Operations at Its Irish Facility
More
February 4, 2010
Israel Supreme Court Prohibits Sun From Exercising Warrant While Temporary Junction In Affect
More
February 2, 2010
Taro Receives FDA Approval For Levetiracetam Tablets
More